Income Taxes (Tables)

12 Months Ended

Dec. 31, 2017

Income Tax Disclosure [Abstract]

Schedule of Income Tax Expense (Benefit)

The income tax benefit attributable to loss before income taxes for the years ended December 31, 2017 and 2016 is as follows:

	2017			2016
Current:
Federal	$	-		$	-
State		(1,789,000	)		-
Foreign		-			-
Total current tax benefit		(1,789,000	)		-
Deferred:
Federal		-			-
State		-			-
Foreign		-			-
Total deferred tax benefit		-			-
Income tax benefit	$	(1,789,000	)	$	-

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the income tax benefit computed at the statutory tax rate to the Company’s effective tax rate is as follows:

	2017			2016
U.S. federal statutory rate		35.00	%		35.00	%
State taxes		(21.84	)%		(5.21	)%
Sale of NJ NOLS and credits		(68.91	)%		-	%
Change in federal statutory rate		(441.07	)%		-	%
Stock based compensation		(5.48	)%		-	%
Other permanent difference due to sale of NJ NOLs and credits		(24.12	)%		-	%
State research and development credits		2.24	%		1.87	%
Other		(12.46	)%		0.97	%
Valuation allowance		467.73	%		(32.63	)%
Effective tax rate		(68.91	)%		-	%

Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets as of December 31, 2017 and 2016 are as follows:

	2017			2016
Deferred tax assets:
Net operating loss carry forwards	$	17,907,000		$	29,861,000
Research and development credits		1,322,000			1,220,000
Nonqualified stock option compensation expense		453,000			537,000
Other temporary book - tax differences		125,000			255,000
Total deferred tax assets		19,807,000			31,873,000
Valuation allowance for deferred tax assets		(19,807,000	)		(31,873,000	)
Net deferred tax assets	$	-		$	-